<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mangia</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Piazzolla</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Giannelli</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Visaggi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Minerva</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Palmieri</surname>
    <given-names>V.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: a real world experience</article-title>. 
  <source>PLoS ONE</source>
  <volume>15</volume>:
  <fpage>e0215783</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0215783</pub-id>
 </mixed-citation>
</ref>
